Guardion Health Sciences (NASDAQ:GHSI) Trading Down 0.3% – Time to Sell?

Guardion Health Sciences, Inc. (NASDAQ:GHSI)’s share price traded down 0.3% during mid-day trading on Tuesday . The stock traded as low as $3.23 and last traded at $3.24. 29,680 shares traded hands during trading, a decline of 73% from the average session volume of 111,760 shares. The stock had previously closed at $3.25.

Guardion Health Sciences Trading Down 0.3 %

The firm has a market capitalization of $4.16 million, a price-to-earnings ratio of -0.81 and a beta of 0.73. The stock’s 50-day moving average is $9.49 and its 200-day moving average is $9.25.

Guardion Health Sciences (NASDAQ:GHSI) last announced its quarterly earnings results on Tuesday, August 13th. The company reported ($1.64) earnings per share (EPS) for the quarter. Guardion Health Sciences had a negative return on equity of 73.69% and a net margin of 22.79%. The company had revenue of $0.07 million for the quarter.

Guardion Health Sciences Dividend Announcement

The company also recently declared a dividend, which was paid on Monday, September 23rd. Stockholders of record on Monday, September 9th were paid a dividend of $5.00 per share. The ex-dividend date was Tuesday, September 24th. Guardion Health Sciences’s payout ratio is -124.38%.

About Guardion Health Sciences

Guardion Health Sciences, Inc, a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment.